CDK4 and renal cell carcinoma: An in silico study recently identified rutin and curcumin, which specifically bind to CCND1 and inhibit its association with CDK4/CDK6 complex, which is required for G1-S phase transition [132], highlighting the potential to disrupt Cyclin D1 signaling pathway during RCC progression.